Patent · US Active

2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist

US8673890B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Han-Cheng Zhang · Lansdale, US
Bruce E. Maryanoff · Robinson Township, US
Kimberly White · North Wales, US
Stephen C. Yabut · North Wales, US
Hong Ye · Lansdale, US
Cailin Chen · New Hope, US

Key dates

Filing date	Oct 28, 2010
Grant date	Mar 18, 2014
Priority date	—
Expiry date	Feb 17, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to novel 2,3-dihydro-1H-isoindol-1-imine derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the thrombin PAR-1 receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.